Health and Wellness Informatics News
Anumana is a venture from biomedical-data company inference. It announced that it received FDA Breakthrough Device Designation.
Amazon Web Services is now accepting digital health applications for the latest cohort. This is for its Healthcare Accelerator. This will target improving health outcomes for underserved communities.
The accelerator will accept 10 startups. Those startups must focus on increasing access to healthcare. It will also reduce disparities by managing social determinants of digital health. The companies will receive connections to venture capital firms. That will also help with business planning, AWS training, and go-to-market planning. This is the second year of AWS’ accelerator in the U.S. It recently launched a UK-based program that begins in March
Applications are due on July 1. The program will begin in late August. This was for its ECG-based AI algorithm. It also got designed for the early detection of pulmonary hypertension.
The Breakthrough Device Designation isn’t a marketing approval from the FDA. But it aims to accelerate the review of products. That could also help treat debilitating or life-threatening conditions.
If the algorithm gets approved in the future, Anumana said it could get downloaded on a physician’s device. The device includes a smartphone or laptop. These can also get accessed on the cloud through an EHR or ECG information management system.
Venky Soundararajan is the cofounder and chief scientific officer of Anumana and inference. He also stated, “Electrophysiology waveforms hold immense untapped potential for detecting diseases earlier in their natural history, particularly for conditions in which earlier diagnosis and therapeutic intervention can prolong survival and improve quality of life.
The FDA’s Breakthrough Device Designation for Anumana’s PH Early Detection Algorithm is one step forward for the field of ECG AI overall, and more saliently, a giant leap forward for PH patients.”
AI-enabled imaging companies Aidoc and Gleamer are partnering. This is to integrate the latter’s BoneView tool for X-rays into Aidoc’s platform.
Gleamer’s solution is another highly valued addition to the suite of industry-leading AI solutions. This also empowers digital health systems to improve patient outcomes. Again, this is across multiple modalities and service lines within the hub-and-spoke model.